Ping Lan
11Patents
1h-index
80Co-inventors
53Inventor score
Filing activity: Sep 21, 2009 → Jul 22, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8933113B2 | Mineralocorticoid receptor antagonists | Chemistry; Metallurgy | 8 | Active |
| US8394969B2 | Cyclic benzimidazole derivatives useful as anti-diabetic agents | Chemistry; Metallurgy | 1 | Active |
| US9487506B2 | Mineralocorticoid receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US8563746B2 | Cyclic benzimidazole derivatives useful as anti-diabetic agents | Chemistry; Metallurgy | 0 | Active |
| US10875851B2 | Factor XIIa inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9708270B2 | Substituted spiropiperidinyl compounds useful as GPR120 agonists | Chemistry; Metallurgy | 0 | Active |
| US10864211B2 | Hydroxy isoxazole compounds useful as GPR120 agonists | Chemistry; Metallurgy | 0 | Active |
| US8329914B2 | Cyclic benzimidazole derivatives useful as anti-diabetic agents | Chemistry; Metallurgy | 0 | Active |
| US11161819B2 | Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists | Chemistry; Metallurgy | 0 | Active |
| US9403807B2 | Mineralocorticoid receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US8410284B2 | Cyclic benzimidazole derivatives useful as anti-diabetic agents | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.